首页> 外文期刊>World Allergy Organization Journal >Probiotics as treatment for food allergies among pediatric patients: a meta-analysis
【24h】

Probiotics as treatment for food allergies among pediatric patients: a meta-analysis

机译:益生菌治疗小儿食物过敏的Meta分析

获取原文
       

摘要

The burden of disease of food allergy is increasing worldwide. The standard of management is allergen avoidance and symptomatic treatment. Probiotics have?been proposed to be beneficial for treatment and prevention of food allergy. To determine the effectiveness of probiotic administration in treating food allergies among pediatric patients. A systematic search of electronic medical literature databases was conducted. Manual search of the reference lists and search for unpublished articles were also done. All randomized controlled trials available from inception until February 19, 2018 were retrieved. The primary outcome of interest was relief of allergic symptoms, while the secondary outcome of interest was inducement of tolerance. Two independent authors did the search, screening, appraisal, and data abstraction. Data analysis and synthesis were done using RevMan 5.3 software. Subgroup analysis was done based on the probiotic strains and time periods in measuring the outcome. Exclusion sensitivity analysis was also done. Nine trials involving 895 pediatric patients with cow’s milk allergy (CMA)?were included in the review. The primary outcome of interest, relief of symptoms, was measured using the scoring index for eczema. Pooled results from two studies showed larger reduction in the scoring index among patients given probiotics, but this effect was imprecise (MD -1.30, 95% CI -3.88, 1.28). For the secondary outcome of interest, pooled results from four studies showed benefit of probiotics in inducing tolerance, but again this result is imprecise with significant heterogeneity (RR 0.58, 95% CI 0.34, 1.00). Subgroup analysis per probiotic strain showed benefit of Lactobacillus rhamnosus GG in inducing tolerance based on two studies involving infants with suspected cow’s milk allergy (RR?=?0.41, 95% CI 0.28 to 0.62). Another subgroup analysis showed a duration-dependent effect associated with probiotic usage, with inducement of tolerance noted after at least 2 years (RR?=?0.44, 95% CI 0.29 to 0.67). Analysis of available evidence shows moderate certainty that the use of probiotics can relieve symptoms of children with cow’s milk allergy. The reduction in certainty is due to imprecise results. Moreover, there is low certainty that probiotics can induce tolerance among children with cow’s milk allergy, due to problems of imprecision and attrition bias. In the subgroup analysis, Lactobacillus rhamnosus GG administration likely results in inducing tolerance among infants with suspected cow’s milk allergy. Only studies on CMA were analyzed since no studies were found on probiotics as treatment for other types of food allergy among children.
机译:全世界食物过敏疾病的负担正在增加。管理的标准是避免过敏原和对症治疗。已经提出益生菌有益于治疗和预防食物过敏。确定益生菌给药在治疗小儿患者食物过敏中的有效性。对电子医学文献数据库进行了系统搜索。还手动搜索了参考列表并搜索了未发表的文章。检索了从开始到2018年2月19日的所有随机对照试验。感兴趣的主要结果是减轻过敏症状,而感兴趣的次要结果是诱导耐受。两名独立作者进行了搜索,筛选,评估和数据抽象。使用RevMan 5.3软件进行数据分析和综合。在评估结果时,根据益生菌菌株和时间段进行了亚组分析。还进行了排除敏感性分析。该评价包括9项试验,涉及895名患牛奶过敏(CMA)的小儿患者。所关注的主要结局(症状缓解)使用湿疹得分指数进行衡量。来自两项研究的汇总结果显示,在服用益生菌的患者中,得分指数的降低幅度更大,但是这种效果并不精确(MD -1.30,95%CI -3.88,1.28)。对于感兴趣的次要结果,来自四项研究的汇总结果显示了益生菌在诱导耐受性方面的优势,但这一结果仍然不精确,具有明显的异质性(RR 0.58,95%CI 0.34,1.00)。每个益生菌菌株的亚组分析显示,鼠李糖乳杆菌GG在诱导耐受性方面的优势是基于两项涉及可疑牛奶过敏婴儿的研究(RR?= 0.41,95%CI 0.28至0.62)。另一个亚组分析显示了与益生菌使用有关的持续时间依赖性效应,至少两年后注意到耐受性的诱导(RR = 0.44,95%CI 0.29至0.67)。对现有证据的分析表明,可以肯定地确定,使用益生菌可以缓解牛奶过敏儿童的症状。确定性的降低是由于结果不准确。此外,由于不精确和磨损偏倚的问题,益生菌对牛奶过敏儿童的耐受性还很低。在亚组分析中,鼠李糖乳杆菌GG的使用可能会导致对怀疑有牛奶过敏的婴儿产生耐受性。由于没有发现关于益生菌作为儿童其他类型食物过敏治疗方法的研究,因此仅分析了有关CMA的研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号